IHC analysis revealed URGCP/URG4 was high expression in 106 (61.6%) cases, and low expression in 66 (38.4%) cases (Table 1), and its expression advanced with larger tumor size (T classification) (Figure 7A), the detailed date were shown as follow: 37.8% for T1 (34/90), 87.8% for T2 (72/82). This evidence concerns the gene URGCP and neoplasm.